ROYAL BANK OF CANADA - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is DFFN and the CUSIP is 253748206. A total of 18 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$010.0%0.00%
Q2 2018$010.0%0.00%
Q1 2018$010.0%0.00%
Q4 2017$010.0%0.00%
Q3 2017$010.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Swift Run Capital 2,508,017$1,369,0000.98%
WHITTIER TRUST CO OF NEVADA INC 135,551$73,0000.01%
Virtu Financial LLC 25,335$14,0000.00%
Signature Financial Management, Inc. 12,350$7,0000.00%
IHT Wealth Management, LLC 3,800$2,0000.00%
THOMPSON SIEGEL & WALMSLEY LLC 2,000$1,0000.00%
Smithfield Trust Co 2,052$1,0000.00%
VANGUARD GROUP INC 904,815$494,0000.00%
ROYAL BANK OF CANADA 1$00.00%
St. Johns Investment Management Company, LLC 23$00.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders